TCW Group’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.13M | Sell |
126,959
-8,243
| -6% | -$138K | 0.02% | 255 |
|
|
2025
Q1 | $2.08M | Buy |
135,202
+26,105
| +24% | +$401K | 0.02% | 249 |
|
|
2024
Q4 | $2.4M | Buy |
109,097
+37,707
| +53% | +$831K | 0.02% | 243 |
|
|
2024
Q3 | $1.29M | Buy |
+71,390
| New | +$1.29M | 0.01% | 283 |
|
|
2016
Q4 | – | Sell |
-71,914
| Closed | -$3.31M | – | 703 |
|
|
2016
Q3 | $3.31M | Sell |
71,914
-63,137
| -47% | -$2.91M | 0.03% | 233 |
|
|
2016
Q2 | $6.78M | Buy |
135,051
+4,715
| +4% | +$237K | 0.05% | 163 |
|
|
2016
Q1 | $6.98M | Buy |
130,336
+29,339
| +29% | +$1.57M | 0.05% | 160 |
|
|
2015
Q4 | $6.63M | Buy |
+100,997
| New | +$6.63M | 0.05% | 166 |
|
|
2015
Q2 | – | Sell |
-35,068
| Closed | -$2.18M | – | 717 |
|
|
2015
Q1 | $2.18M | Sell |
35,068
-2,711
| -7% | -$169K | 0.01% | 609 |
|
|
2014
Q4 | $2.17M | Buy |
37,779
+2,729
| +8% | +$157K | 0.01% | 602 |
|
|
2014
Q3 | $1.88M | Buy |
35,050
+12,593
| +56% | +$677K | 0.01% | 672 |
|
|
2014
Q2 | $1.18M | Buy |
+22,457
| New | +$1.18M | ﹤0.01% | 694 |
|